| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |